Literature DB >> 23529063

Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.

Sengwee Toh, Meghan A Baker, Jeffrey S Brown, Cynthia Kornegay, Richard Platt.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23529063     DOI： 10.1001/jamainternmed.2013.3004

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  16 in total

1.  Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

Authors:  S V Wang; P Verpillat; J A Rassen; A Patrick; E M Garry; D B Bartels
Journal:  Clin Pharmacol Ther       Date:  2016-03       Impact factor: 6.875

Review 2.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

Review 3.  Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.

Authors:  Abhishek Sharma; Saurabh Thakar; Carl J Lavie; Jalaj Garg; Parasuram Krishnamoorthy; Ondrej Sochor; Armin Arbab-Zadeh; Edgar Lichstein
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

4.  A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment.

Authors:  Joshua J Gagne; Shirley V Wang; Jeremy A Rassen; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-04-30       Impact factor: 2.890

5.  Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Authors:  Edward J Mills; Kristian Thorlund; Shawn Eapen; Ping Wu; Judith J Prochaska
Journal:  Circulation       Date:  2013-12-09       Impact factor: 29.690

6.  Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods.

Authors:  Rachel L Richesson; Jimeng Sun; Jyotishman Pathak; Abel N Kho; Joshua C Denny
Journal:  Artif Intell Med       Date:  2016-06-25       Impact factor: 5.326

Review 7.  A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system.

Authors:  Christine Y Lu; Marc S Williams; Geoffrey S Ginsburg; Sengwee Toh; Jeff S Brown; Muin J Khoury
Journal:  Genet Med       Date:  2017-08-10       Impact factor: 8.822

8.  Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study.

Authors:  Daniel Kotz; Wolfgang Viechtbauer; Colin Simpson; Onno C P van Schayck; Robert West; Aziz Sheikh
Journal:  Lancet Respir Med       Date:  2015-09-06       Impact factor: 30.700

9.  A system to build distributed multivariate models and manage disparate data sharing policies: implementation in the scalable national network for effectiveness research.

Authors:  Daniella Meeker; Xiaoqian Jiang; Michael E Matheny; Claudiu Farcas; Michel D'Arcy; Laura Pearlman; Lavanya Nookala; Michele E Day; Katherine K Kim; Hyeoneui Kim; Aziz Boxwala; Robert El-Kareh; Grace M Kuo; Frederic S Resnic; Carl Kesselman; Lucila Ohno-Machado
Journal:  J Am Med Inform Assoc       Date:  2015-07-03       Impact factor: 4.497

10.  The importance and implications of comparator selection in pharmacoepidemiologic research.

Authors:  Monica D'Arcy; Til Stürmer; Jennifer L Lund
Journal:  Curr Epidemiol Rep       Date:  2018-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.